|
AU5588298A
(en)
|
1996-12-02 |
1998-06-29 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated delivery of dna to cells of the liver
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
US7238346B2
(en)
|
2002-07-08 |
2007-07-03 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
High capacity recombinant adenoviral vector for treatment of hemophilia A
|
|
PT1675956E
(pt)
|
2003-10-21 |
2010-11-04 |
Merck Serono Sa |
Sequência mínima de adn que actua como um isolador de cromatina e sua utilização na expressão de proteína
|
|
JPWO2006043354A1
(ja)
|
2004-10-20 |
2008-05-22 |
独立行政法人放射線医学総合研究所 |
組込型の低線量放射線誘導性ベクター
|
|
JP2008543283A
(ja)
|
2005-06-10 |
2008-12-04 |
ジェネンテック・インコーポレーテッド |
インスレーターエレメントを含むベクターを使用する抗体発現の改良
|
|
CN101965409A
(zh)
|
2007-11-01 |
2011-02-02 |
罗切斯特大学 |
具有增加的稳定性的重组因子viii
|
|
CA2722238C
(en)
|
2008-04-22 |
2017-11-28 |
Life Sciences Research Partners Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
WO2009134681A2
(en)
*
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
GB0911870D0
(en)
|
2009-07-08 |
2009-08-19 |
Ucl Business Plc |
Optimised coding sequence and promoter
|
|
CA2848417C
(en)
|
2011-09-21 |
2023-05-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of transgene expression
|
|
CA3018046A1
(en)
*
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
CN104271150A
(zh)
|
2012-01-12 |
2015-01-07 |
比奥根艾迪克Ma公司 |
嵌合因子viii多肽及其用途
|
|
EP3196301B1
(en)
|
2012-07-11 |
2018-10-17 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of monogenic diseases
|
|
JP2015529466A
(ja)
|
2012-09-14 |
2015-10-08 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
鎌状赤血球症の幹細胞遺伝子治療のためのレンチウイルスベクター
|
|
AU2013336601B2
(en)
|
2012-10-26 |
2018-01-25 |
Vrije Universiteit Brussel |
Vector for liver-directed gene therapy of hemophilia and methods and use thereof
|
|
AU2014246731A1
(en)
|
2013-03-30 |
2015-11-19 |
Usha Biotech Limited |
Methods and constructs for expressing biologically active proteins in mammalian cells
|
|
EP3044231B1
(en)
|
2013-09-12 |
2020-08-05 |
BioMarin Pharmaceutical Inc. |
Aav vectors comprising a gene encoding factor viii
|
|
CN105940013B
(zh)
|
2013-12-09 |
2020-03-27 |
桑格摩生物科学股份有限公司 |
用于治疗血友病的方法和组合物
|
|
AU2015204646B2
(en)
|
2014-01-10 |
2020-08-27 |
Bioverativ Therapeutics Inc. |
Factor VIII chimeric proteins and uses thereof
|
|
MX388739B
(es)
|
2015-02-06 |
2025-03-20 |
Univ North Carolina Chapel Hill |
Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso.
|
|
EP3283126B1
(en)
|
2015-04-16 |
2019-11-06 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
EP3294064A1
(en)
|
2015-05-11 |
2018-03-21 |
Bayer CropScience AG |
Herbicide combinations comprising l-glufosinate and indaziflam
|
|
AU2016291778B2
(en)
|
2015-07-13 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
TW202446416A
(zh)
|
2015-09-24 |
2024-12-01 |
美商拜奧馬林製藥公司 |
腺相關病毒因子viii載體、相關病毒粒子及包含其之治療調配物
|
|
MY189674A
(en)
|
2015-10-28 |
2022-02-24 |
Sangamo Therapeutics Inc |
Liver-specific constructs, factor viii expression cassettes and methods of use thereof
|
|
EA202190827A1
(ru)
*
|
2015-11-13 |
2021-11-30 |
Баксалта Инкорпорейтед |
Вирусные векторы, кодирующие рекомбинантные варианты fviii с повышенной экспрессией для генной терапии гемофилии a
|
|
PE20200722A1
(es)
*
|
2017-08-01 |
2020-07-21 |
Spark Therapeutics Inc |
Metodos de terapia genica del factor viii (fviii)
|